Skip to main content
. Author manuscript; available in PMC: 2023 May 2.
Published in final edited form as: J Surg Oncol. 2014 Jun 24;110(4):375–382. doi: 10.1002/jso.23656

TABLE II.

Acute Grade 3 or Greater Toxicity

Toxicity EBRT CCRT P-Value

Dermatitis 4 (9.1%) 4 (20.0%) 0.221
Nausea 1 (2.3%) 0 (0%) 0.497
Vomiting 1 (2.3%) 0 (0%) 0.497
Mucositis 10 (22.7%) 3 (15.0%) 0.476
Xerostomia 1 (2.3%) 0 (0%) 0.497
Dysphagia 5 (11.4%) 6 (30.0%) 0.067
Hoarseness 0 (0%) 2 (10.0%) 0.033
Fatigue 2 (4.5%) 1 (5.0%) 0.936

Analysis limited to 44 and 20 patients, respectively. CCRT, concurrent chemoradiation therapy; EBRT, external beam radiation therapy.